Related Experiment Video
Updated: Aug 30, 2025
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.3K
Dose escalation by brachytherapy for gynecological cancers
Summary
Brachytherapy (BT) is a focused radiation therapy for gynecologic cancers, especially cervical cancer. Technological advancements have improved treatment efficacy and patient survival, with ongoing research aiming for personalized therapies.
Area of Science:
- Oncology
- Radiation Oncology
- Gynecologic Oncology
Background:
- Brachytherapy (BT) is a cornerstone radiation therapy for gynecologic malignancies, particularly cervical cancer, with over a century of clinical application.
- Historically, BT has evolved significantly from early techniques to modern approaches, driven by technological innovations.
- Its efficacy in delivering high radiation doses to localized tumors while sparing normal tissues is well-established.
Purpose of the Study:
- To review the historical evolution and technological advancements in gynecologic brachytherapy.
- To highlight the impact of these advancements on treatment outcomes, including local control and survival.
- To discuss current research directions for further personalization and toxicity reduction in BT.
Main Methods:
- Historical review of brachytherapy techniques and technological developments in gynecologic oncology.
- Analysis of the impact of technological advancements (e.g., HDR sources, remote afterloaders, 3D image guidance) on treatment efficacy.
- Synthesis of current research trends, including biomarker research, advanced imaging, and radiosensitizing agents.
Main Results:
- Technological advancements, including high-dose-rate (HDR) sources, remote afterloaders, novel applicators, and 3D image guidance, have significantly improved tumor dose delivery.
- These improvements have led to enhanced local control and survival rates for patients with gynecologic cancers.
- Brachytherapy remains an integral and effective treatment modality for gynecologic malignancies.
Conclusions:
- Gynecologic brachytherapy has undergone substantial technological evolution, enhancing its therapeutic ratio.
- Current research focuses on integrating biomarkers, advanced imaging, and novel therapies to further personalize BT and minimize treatment toxicity.
- Continued innovation in brachytherapy promises improved outcomes and reduced side effects for gynecologic cancer patients.
Keywords:
BrachytherapyCancers gynécologiquesCuriethérapieDose escalationEscalade de doseGynecological cancersMore Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.5K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.9K
Related Concept Videos
01:01Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K